These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24797365)

  • 1. Impact of pulmonary hypertension on exercise performance in patients with interstitial lung disease undergoing evaluation for lung transplantation.
    Armstrong HF; Schulze PC; Bacchetta M; Thirapatarapong W; Bartels MN
    Respirology; 2014 Jul; 19(5):675-82. PubMed ID: 24797365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing pulmonary hypertension in interstitial lung disease by ventilation and perfusion defects measured by cardiopulmonary exercise testing.
    Armstrong HF; Thirapatarapong W; Dussault NE; Bartels MN
    Respiration; 2013; 86(5):407-13. PubMed ID: 23735701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary vascular response patterns during exercise in interstitial lung disease.
    Degani-Costa LH; Levarge B; Digumarthy SR; Eisman AS; Harris RS; Lewis GD
    Eur Respir J; 2015 Sep; 46(3):738-49. PubMed ID: 25976688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiorespiratory responses to 6-minute walk test in interstitial lung disease: not always a submaximal test.
    Holland AE; Dowman L; Fiore J; Brazzale D; Hill CJ; McDonald CF
    BMC Pulm Med; 2014 Aug; 14():136. PubMed ID: 25113781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borderline pulmonary hypertension is associated with exercise intolerance and increased risk for acute exacerbation in patients with interstitial lung disease.
    Nemoto K; Oh-Ishi S; Akiyama T; Yabuuchi Y; Goto H; Nonaka M; Sasatani Y; Tachi H; Arai N; Ishikawa H; Hyodo K; Hase I; Miura Y; Takaku T; Hayashihara K; Saito T
    BMC Pulm Med; 2019 Sep; 19(1):167. PubMed ID: 31477076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventilation distribution as a contributor to the functional exercise capacity in patients with systemic sclerosis-associated interstitial lung disease without pulmonary hypertension.
    Andrade FM; Oliveira AD; Lopes AJ
    Braz J Med Biol Res; 2019; 52(8):e8513. PubMed ID: 31365695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiopulmonary exercise factors predict survival in patients with advanced interstitial lung disease referred for lung transplantation.
    Layton AM; Armstrong HF; Kim HP; Meza KS; D'Ovidio F; Arcasoy SM
    Respir Med; 2017 May; 126():59-67. PubMed ID: 28427551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can a New Scoring System Improve Prediction of Pulmonary Hypertension in Newly Recognised Interstitial Lung Diseases?
    Sobiecka M; Lewandowska K; Kober J; Franczuk M; Skoczylas A; Tomkowski W; Kuś J; Szturmowicz M
    Lung; 2020 Jun; 198(3):547-554. PubMed ID: 32206858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 100 % oxygen during exercise in patients with interstitial lung disease.
    Cournoyer J; Ramos CF; Sturgill B; Tang F; DeLuca N; Mirsaeidi M; Jackson RM
    Respir Physiol Neurobiol; 2020 Mar; 274():103367. PubMed ID: 31911201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease.
    Oliveira RKF; Waxman AB; Hoover PJ; Dellaripa PF; Systrom DM
    Chest; 2020 Jul; 158(1):350-358. PubMed ID: 32173491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiopulmonary Exercise Testing in Combined Pulmonary Fibrosis and Emphysema.
    Westhoff M; Litterst P; Ewert R
    Respiration; 2021; 100(5):395-403. PubMed ID: 33657565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited Exercise Capacity in Patients with Systemic Sclerosis: Identifying Contributing Factors with Cardiopulmonary Exercise Testing.
    Martis N; Queyrel-Moranne V; Launay D; Neviere R; Fuzibet JG; Marquette CH; Leroy S
    J Rheumatol; 2018 Jan; 45(1):95-102. PubMed ID: 29093153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peak oxygen uptake during the six-minute walk test in diffuse interstitial lung disease and pulmonary hypertension].
    Blanco I; Villaquirán C; Valera JL; Molina-Molina M; Xaubet A; Rodríguez-Roisin R; Barberà JA; Roca J
    Arch Bronconeumol; 2010 Mar; 46(3):122-8. PubMed ID: 20138698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Summed Score From Cardiopulmonary Exercise Test Parameters Predicts 1-Year Mortality in Newly Diagnosed Interstitial Lung Disease.
    Cheng YY; Lee YC; Liao YW; Liu MC; Wu YC; Hsu CY; Yu YH; Fu PK
    Respir Care; 2024 Sep; 69(10):1305-1313. PubMed ID: 38889928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
    Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing walking training in interstitial lung disease from the 6-minute walk test.
    Nakazawa A; Dowman LM; Cox NS; Brazzale DJ; McDonald CF; Hill CJ; Lee A; Holland AE
    Physiother Theory Pract; 2023 Apr; 39(4):873-877. PubMed ID: 35073825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.
    Vandecasteele E; Melsens K; De Keyser F; De Pauw M; Deschepper E; Decuman S; Piette Y; Thevissen K; Brusselle G; Smith V
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):95-101. PubMed ID: 30183593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing cardiopulmonary exercise testing in severe COPD patients with and without pulmonary hypertension.
    Thirapatarapong W; Armstrong HF; Bartels MN
    Heart Lung Circ; 2014 Sep; 23(9):833-40. PubMed ID: 24793962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of end-tidal CO
    Higashi A; Dohi Y; Yamabe S; Kinoshita H; Sada Y; Kitagawa T; Hidaka T; Kurisu S; Yamamoto H; Yasunobu Y; Kihara Y
    Heart Vessels; 2017 Nov; 32(11):1350-1357. PubMed ID: 28560485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.